What does GOLDENWELL BIOTECH, INC. do?

GOLDENWELL BIOTECH, INC. is a public company in the Food and Kindred Products industry, incorporated in NV. It is registered with the SEC under CIK 0001800373 and trades on OTC under the ticker GWLL.

What is GOLDENWELL BIOTECH, INC.'s annual revenue?

GOLDENWELL BIOTECH, INC. reported $139 in revenue for fiscal year 2024, according to its 10-K filing with the SEC.

Is GOLDENWELL BIOTECH, INC. profitable?

GOLDENWELL BIOTECH, INC. reported a net loss of $0.13M in FY2024. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has GOLDENWELL BIOTECH, INC. made?

GOLDENWELL BIOTECH, INC. has filed 72 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

GOLDENWELL BIOTECH, INC.

GWLL OTC CIK: 0001800373 Food and Kindred Products Inc. in NV

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 72 filings →

Form	Description	Date
10-Q	FORM 10-Q	Dec 8, 2025
10-Q	FORM 10-Q	Sep 12, 2025
8-K	FORM 8-K	Aug 19, 2025
NT 10-Q	NT 10-Q	Aug 14, 2025
10-Q	FORM 10-Q	May 27, 2025
10-K	FORM 10-K	May 15, 2025
NT 10-Q	FORM NT 10-Q	May 14, 2025
NT 10-K	NT 10-K	Apr 1, 2025
8-K	FORM 8-K	Jan 23, 2025
10-Q	FORM 10-Q	Nov 26, 2024

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for GOLDENWELL BIOTECH, INC.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $139 (FY2024)
Net Income: ($131.5K) (FY2024)
Total Assets: $224.2K (FY2024)
Operating Income: ($123.1K)

Full financials →

Details

CIK: 0001800373
Ticker: GWLL
Exchange: OTC
Incorporated: NV
First Filing: 2020
Total Filings: 72

Food and Kindred Products rankings →